|Day Low/High||3,117.17 / 3,175.04|
|52 Wk Low/High||1,626.03 / 3,552.25|
As the president's press conference on China approaches, there is ample reason for some risk-off behavior. Meantime, Zscaler's earnings beat is a good time to take a profit.
I'll be taking at least a third of my long off ahead of the numbers this afternoon.
Let's take stock of who's likely to come out ahead in this winner-take-all marathon.
It's about HBO Max, what to do with DirecTV, and the sustainable dividend yield.
Retail investors have been outperforming hedge fund managers and institutions, though the verdict is still out on whether the party will last.
* Banks +8% as growth is in the red on the day * Given the overweighting in portfolios, exchange-traded funds and jndexes of Microsoft and FAANG stocks -- a relatively small disintermediation could fuel banks and other value names. * Sell in May an...
The thought that one of these more than 100 attempts to tame Covid-19 pays off.
Predicting a pivot from growth to value after a decade of the contrary is a tough task. But I am focused on the developing possibility. Today (in FANG terms), Facebook is up by one +1%, Amazon is barely higher, Netflix is under pressure, and Alphabe...
A look at those stocks likely to lead in the short- and long-term, the headlines out of China and Hong Kong, and the import of fiscal stimulus.
GOOGL has made an impressive recovery since the middle of March.
Charles Gave is the founding partner of Gavekal Research. He has been researching tactical asset allocation for four decades. He cofounded a $10 billion money management company, Cusitor-Eaton Asset Management, where he was chief investment officer ...
Adjustments people and companies have made due to the pandemic are likely to outlast the virus in some measure, and those firms that don't adapt face trouble.
As State economies begin the slow process of reopening, the Fed is there to support market function. Facebook's latest e-commerce foray has investors cheering.
Search is still by far Google's most profitable business, and antitrust charges aimed at other parts of Alphabet's empire likely wouldn't have a major profit impact.
I like WMT, and following an earnings related trade, I'll repurchase if the shares sink back into the low $120's.
Watching Moderna, Microsoft and FedEx as risk continues to be a central market theme, despite Monday's rally.
Let's step back and look at this market that has abandoned all sorts of safety and went all in on the stocks of companies based on the Fed's words and a promising Moderna study.
I would be a buyer of a call spread in this ETF.
* The bears' skepticism (and cautious market positioning) coupled with their collective cynicism towards medical and scientific innovation, and the inevitability of the curve's flattening along with an "all in" Fed, have fueled the market recovery f...
Because they could be the next Netflix or Amazon. To me that's enough.
* I am watching closely for a change in leadership and a pivot from growth to value * A skeptical view of a bifurcated market led by a handful of high growth stocks (FAANG plus MSFT) that have done the market's heavy lifting * Reviewing the attribut...
Our government made businesses insolvent to conquer a disease it can't conquer, and now solid businesses that could have thrived, that could have been the next Walmart for all we know, are closing.
These high-quality companies have strong balance sheets and operate in high-demand markets poised to do well through any economic crisis.
Trump administration taps former GlaxoSmithKline exec as head of vaccine task force, and how I'm playing Walmart and Datadog.
The action Wednesday was a return to typical bear market trading, as stocks moved in a correlated way.
Let's look at the stocks that will get crushed and that you can't touch right now.
Regarding Mikey's observation it is important to note that: * These guys can change on a dime. * These guys will change if the health and medical community come up with therapeutic relief or a vaccine to Covid-19. * Like all of us, these guys are of...
Tuesday's heavy selling into the close may be the sell signal that traders have been waiting for. Regardless, ensure you are managing risk tightly as volatility increases.
We can't wait for a vaccine, but we can follow logical guidelines for staying as safe as possible, helping us avoid another Great Depression.